Association of Statin Use With the In-Hospital Outcomes of 2019-Coronavirus Disease Patients: A Retrospective Study

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

First Case of 2019 Novel Coronavirus in the United States

(2020) Michelle L. Holshue et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury

(2020) Yingxia Liu et al.   Science China-Life Sciences

The characteristics of 50 hospitalized COVID-19 patients with and without ARDS

(2020) Michael Dreher et al.   Deutsches Arzteblatt International

Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series

(2020) Michael G Argenziano et al.   BMJ-British Medical Journal

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China

(2020) Chaomin Wu et al.   JAMA Internal Medicine

Are statins safe in patients with COVID-19?

(2020) Dean G. Karalis   Journal of Clinical Lipidology

The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents

(2020) Anton De Spiegeleer et al.   Journal of the American Medical Directors Association

Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: Role of epigenetic histone modifications

(2015) Kulbhushan Tikoo et al.   BIOCHEMICAL PHARMACOLOGY

A Practical Treatment for Patients With Ebola Virus Disease

(2014) D. S. Fedson   JOURNAL OF INFECTIOUS DISEASES

World Medical Association Declaration of Helsinki

(2013)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Is Statin Use Associated with Reduced Mortality After Pneumonia? A Systematic Review and Meta-analysis

(2012) Vineet Chopra et al.   AMERICAN JOURNAL OF MEDICINE

Emerging roles for cholesterol and lipoproteins in lung disease

(2012) Kymberly M. Gowdy et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist

(2011) Roelie M Wösten-van Asperen et al.   JOURNAL OF PATHOLOGY

The effect of statins on mortality from severe infections and sepsis: A systematic review and meta-analysis

(2010) Surinder Janda et al.   JOURNAL OF CRITICAL CARE

Statin Treatment and Mortality in Bacterial Infections – A Systematic Review and Meta-Analysis

(2010) Linda Björkhem-Bergman et al.   PLoS One

Statins in community acquired pneumonia: Evidence from experimental and clinical studies

(2010) James D. Chalmers et al.   RESPIRATORY MEDICINE

Statins for the Prevention and Treatment of Infections

(2009) Imad M. Tleyjeh   ARCHIVES OF INTERNAL MEDICINE

Statins for community-acquired pneumonia: current state of the science

(2009) D. Viasus et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study

(2008) A. I. Blamoun et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia

(2007) E. M. Mortensen et al.   EUROPEAN RESPIRATORY JOURNAL